These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 23559086
1. Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A, Molitch ME, Merriam GR. J Clin Endocrinol Metab; 2013 Jun; 98(6):2422-9. PubMed ID: 23559086 [Abstract] [Full Text] [Related]
2. Macimorelin as a Diagnostic Test for Adult GH Deficiency. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Medic-Stojanoska M, Schopohl J, Zakrzewska A, Pekic S, Bolanowski M, Swerdloff R, Wang C, Blevins T, Marcelli M, Ammer N, Sachse R, Yuen KCJ. J Clin Endocrinol Metab; 2018 Aug 01; 103(8):3083-3093. PubMed ID: 29860473 [Abstract] [Full Text] [Related]
3. The macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis. Agrawal V, Garcia JM. Expert Rev Mol Diagn; 2014 Jul 01; 14(6):647-54. PubMed ID: 24834478 [Abstract] [Full Text] [Related]
8. Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. Chanson P, Cailleux-Bounacer A, Kuhn JM, Weryha G, Chabre O, Borson-Chazot F, Dubois S, Vincent-Dejean C, Brue T, Fedou C, Bresson JL, Demolis P, Souberbielle JC. J Clin Endocrinol Metab; 2010 Aug 01; 95(8):3684-92. PubMed ID: 20484474 [Abstract] [Full Text] [Related]
9. Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study. Klaus B, Sachse R, Ammer N, Kelepouris N, Ostrow V. Growth Horm IGF Res; 2020 Jun 01; 52():101321. PubMed ID: 32325373 [Abstract] [Full Text] [Related]
11. Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Swerdloff R, Wang C, Fleming RR, Cohen F, Ammer N, Mueller G, Kelepouris N, Strobl F, Ostrow V, Yuen KCJ. Endocr Connect; 2021 Jan 01; 10(1):76-83. PubMed ID: 33320108 [Abstract] [Full Text] [Related]
12. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF. Lancet; 2000 Sep 30; 356(9236):1137-42. PubMed ID: 11030292 [Abstract] [Full Text] [Related]
13. Serum ghrelin levels in growth hormone-sufficient and growth hormone-deficient patients during growth hormone-releasing hormone plus arginine test. Tarantini B, Ciuoli C, Checchi S, Montanaro A, Bonato V, Theodoropoulou A, Pasqui L, Pacini F. J Endocrinol Invest; 2009 Apr 30; 32(4):335-7. PubMed ID: 19636202 [Abstract] [Full Text] [Related]
15. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Apr 30; 84(4):1277-82. PubMed ID: 10199767 [Abstract] [Full Text] [Related]
17. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone. Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A. J Clin Endocrinol Metab; 2000 Mar 30; 85(3):1310-5. PubMed ID: 10720081 [Abstract] [Full Text] [Related]